Fiebre Aftosa / Foot and Mouth Disease Antigenic variation of foot-and-mouth disease virus serotype A. Ludi A, Horton D, Li Y, Mahapatra M, King D, Knowles N, Russell C, Paton D, Wood J, Smith D, Hammond J. J Gen Virol. 2013 Nov
 Availability of a fetal goat tongue cell line ZZ-R 127 for isolation of Foot-and-mouth disease virus (FMDV) from clinical samples collected from animals experimentally infected with FMDV. Fukai K, Onozato H, Kitano R, Yamazoe R, Morioka K, Yamada M, Ohashi S, Yoshida K, Kanno T. J Vet Diagn Invest. 2013 Oct  The economic impacts of foot and mouth disease - What are they, how big are they and where do they occur? Knight-Jones TJ, Rushton J. Prev Vet Med. 2013 Nov;112(3-4):161-73  Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development. Zheng H, Guo J, Jin Y, Yang F, He J, Lv L, Zhang K, Wu Q, Liu X, Cai X. PLoS ONE 2013; 8(1): e55228 Evaluation of the benefit of emergency vaccination in a foot-and-mouth disease free country with low livestock density. Dürr S, Fasel-Clemenz C, Thür B, Schwermer H, Doherr MG, zu Dohna H, Carpenter TE, Perler L, Hadorn DC. Prev Vet Med. 2013 Oct Identification of factors associated with increased excretion of foot-and-mouth disease virus. Bravo de Rueda C, Dekker A, Eblé PL, de Jong MC. Prev Vet Med. 2013 Oct
 A partial deletion in non-structural protein 3A can attenuate foot-and-mouth disease virus in cattle. Pacheco JM, Gladue DP, Holinka LG, Arzt J, Bishop E, Smoliga G, Pauszek SJ, Bracht AJ, O'Donnell V, Fernandez-Sainz I, Fletcher P, Piccone ME, Rodriguez LL, Borca MV. Virology. 2013 Nov;446(1-2):260-7  Reconstructing geographical movements and host species transitions of foot-and-mouth disease Virus serotype SAT 2. Hall MD, Knowles NJ, Wadsworth J, Rambaut A, Woolhouse ME. MBio. 2013 Oct;4 (5)  Reconstructing the origin and transmission dynamics of the 1967-68 foot-and-mouth disease epidemic in the United Kingdom. Wright CF, Knowles NJ, Di Nardo A, Paton DJ, Haydon DT, King DP. Infect Genet Evol. 2013 Dec; 20: 230-8  A review of OIE country status recovery using vaccinate-to-live versus vaccinate-to-die foot-and-mouth disease response policies II: waiting periods after emergency vaccination in FMD free countries. Geale DW, Barnett PV, Clarke GW, Davis J, Kasari TR. Transbound Emerg Dis. 2013 Oct  Targeted delivery of VP1 antigen of foot-and-mouth disease virus to M cells enhances the antigen-specific systemic and mucosal immune response. Kim SH, Lee HY, Jang YS. Immune Netw. 2013 Aug;13 (4): 157-62 DESTACADOS
Proposed terms and concepts for describing and evaluating animal-health surveillance systems. Hoinville LJ, Alban L, Drewe JA, Gibbens JC, Gustafson L, Häsler B, Saegerman C, Salman M, Stärk KD. Prev Vet Med. 2013 Oct;112(1-2):1-12 Transdisciplinary research for complex One Health issues: A scoping review of key concepts. Min B, Allen-Scott LK, Buntain B. Prev Vet Med. 2013 Nov; 112(3-4):222-9
|
Científicos españoles desarrollan una nueva vacuna frente a la fiebre aftosa
Nenhum comentário:
Postar um comentário